by Angela Guess
A recent press release states, “Bioz, Inc. came out of stealth today with the introduction of the world’s first search engine for life science experimentation to speed scientific research into finding cures for diseases and to accelerate drug discovery. Bioz has been enthusiastically welcomed in scientific communities via an early beta program. Currently, over 30,000 users from academic research labs and industry R&D labs, from more than 1,000 universities and biopharma companies, from 40 countries are using Bioz. The company was co-founded by serial entrepreneur and CEO Daniel Levitt, and accomplished Stanford research scientist Karin Lachmi, Ph.D., Chief Scientific Officer at Bioz.”
The release goes on, “Each year, researchers in academia and biopharma spend $80 billion to purchase millions of products (reagents, consumables and instruments) for use in life science experiments. Some of these products have very high failure rates; a case in point are antibodies that don’t work up to 50 percent of the time, and yet before Bioz there was no easy way for researchers to quickly find, compare and select the products that would work best in their specific assays and experiments.”
It continues, “The Bioz cloud platform’s patent-pending software architecture taps the latest advances in Natural Language Processing (NLP) and Machine Learning (ML) to mine and structure hundreds of millions of pages of complex and unstructured scientific papers, placing an unprecedented amount of summarized scientific experimentation knowledge at researchers’ fingertips. The Bioz platform helps researchers select products, plan experiments, write papers, apply for grants and collaborate, speeding up experimentation and drug discovery.”
Read more at MarketWired.
Photo credit: Bioz